Medical Properties Trust, Inc. (MPW)
Official siteREIT - HEALTHCARE FACILITIES
Last updated: Jan 30, 2026 at 4:00 PM ET
Medical Properties Trust, Inc. (MPW) Financials: Revenue, Profit and Cash Flow
Medical Properties Trust reported revenue of $995.55M for the fiscal year ended Dec 31, 2024, up 14.2% from the year before. That year, net income was -$2.41B with a net margin of -242.1%, operating cash flow was $245.48M and free cash flow was $60.08M. The quarter ended Sep 30, 2025 had revenue of $237.52M and net income of -$77.73M.
Revenue and Margins
The operating margin was 38.9% in the fiscal year ended Dec 2024. Over the 9 years to Dec 2024, revenue grew from $441.88M, a compound annual rate of 9.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2024 | $995.55M | +14.2% | 97.3% | 38.9% | -242.1% |
| Dec 2023 | $871.80M | -43.5% | 95.2% | 9.3% | -63.8% |
| Dec 2022 | $1.54B | -0.1% | 97.0% | 65.1% | 58.5% |
| Dec 2021 | $1.54B | +23.6% | 97.5% | 67.2% | 42.5% |
| Dec 2020 | $1.25B | +43.5% | 98.0% | 66.3% | 34.5% |
| Dec 2019 | $870.25M | +10.9% | 97.2% | 86.2% | 43.1% |
| Dec 2018 | $784.52M | +11.3% | 98.8% | 71.7% | 129.6% |
| Dec 2017 | $704.75M | +30.2% | 99.2% | 68.9% | 41.1% |
| Dec 2016 | $541.14M | +22.5% | 99.5% | 63.1% | 41.6% |
| Dec 2015 | $441.88M | N/A | 99.1% | 59.6% | 31.6% |
Income Statement
In the fiscal year ended Dec 2024, the net loss widened from the year before. In the quarter ended Sep 2025, the net loss narrowed from the same quarter a year earlier.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $995.55M | $871.80M | $1.54B | $1.54B | $1.25B | $870.25M | $784.52M | $704.75M | $541.14M | $441.88M |
| Cost of revenue | $27.25M | $41.57M | $45.70M | $39.10M | $24.89M | $23.99M | $9.24M | $5.81M | $2.71M | $3.79M |
| Gross profit | $968.29M | $830.23M | $1.50B | $1.51B | $1.22B | $846.26M | $775.28M | $698.93M | $538.42M | $438.09M |
| Operating income | $386.85M | $81.28M | $1.00B | $1.04B | $828.44M | $749.85M | $562.12M | $485.58M | $341.64M | $263.24M |
| Net income | -$2.41B | -$556.48M | $902.60M | $656.02M | $431.45M | $374.68M | $1.02B | $289.79M | $225.05M | $139.60M |
| EBITDA | $840.60M | $697.41M | $1.35B | $1.37B | $1.10B | $754.11M | N/A | $647.21M | $476.31M | $334.14M |
Quarterly
| Line item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $237.52M | $240.36M | $223.80M | $235.27M | $225.83M | $266.56M | $271.32M | -$122.38M | $306.58M | $349.62M | $361.56M | $387.68M |
| Gross profit | $161.54M | $162.78M | $216.76M | $225.49M | $220.83M | $258.90M | $266.50M | -$125.68M | $300.09M | $324.94M | $354.45M | $379.98M |
| Operating income | $123.80M | $136.58M | $110.28M | $197.00M | -$20.67M | $121.33M | $157.56M | -$233.13M | $184.18M | $289.34M | $312.73M | $337.09M |
| Net income | -$77.73M | -$98.58M | -$118.28M | -$412.85M | -$801.16M | -$320.63M | -$875.63M | -$663.94M | $116.71M | -$42.04M | $32.79M | -$140.47M |
Balance Sheet
As of Dec 2024, total debt of $8.85B exceeded cash and equivalents by $8.52B.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $14.29B | $18.30B | $19.66B | $20.52B | $16.83B | $14.47B | $8.84B | $9.02B | $6.42B | $5.61B |
| Current assets | $1.31B | $1.40B | $1.72B | $2.57B | $1.94B | $4.51B | $1.07B | $436.03M | $257.80M | $324.63M |
| Cash and equivalents | $332.33M | $250.02M | $235.67M | $459.23M | $549.88M | $1.46B | $820.87M | $171.47M | $83.24M | $195.54M |
| Total liabilities | $9.46B | $10.67B | $11.06B | $12.07B | $9.49B | $7.44B | $4.28B | $5.19B | $3.17B | $3.50B |
| Short-term debt | $361.73M | $1.51B | $929.58M | $1.60B | $165.41M | $5.60M | $28.06M | $840.81M | $290.00M | $1.10B |
| Long-term debt | $8.49B | $8.55B | $10.27B | $11.28B | $8.87B | $7.02B | $4.04B | $4.90B | $2.91B | $3.32B |
| Shareholder equity | $4.83B | $7.63B | $8.59B | $8.44B | $7.34B | $7.03B | $4.55B | $3.82B | $3.25B | $2.10B |
Quarterly
| Line item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $14.92B | $15.15B | $14.85B | $14.29B | $15.24B | $16.19B | $17.30B | $18.30B | $19.00B | $19.20B | $19.65B | $19.66B |
| Total liabilities | $10.26B | $10.32B | $10.09B | $9.46B | $9.80B | $10.00B | $10.60B | $10.67B | $10.72B | $10.89B | $11.21B | $11.06B |
| Cash and equivalents | $396.58M | $509.83M | $673.48M | $332.33M | $275.62M | $606.55M | $224.34M | $250.02M | $340.06M | $324.05M | $302.32M | $235.67M |
| Shareholder equity | $4.66B | $4.83B | $4.76B | $4.83B | $5.44B | $6.19B | $6.70B | $7.63B | $8.28B | $8.31B | $8.44B | $8.59B |
Cash Flow
In the fiscal year ended Dec 2024, free cash flow was 24.5% of operating cash flow. Dividends came to 534.4% of it.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $245.48M | $505.79M | $739.01M | $811.66M | $617.64M | $494.12M | $449.09M | $363.10M | $264.68M | $207.00M |
| Capital expenditures | $185.41M | $529.35M | $1.33B | $65.55M | $4.25B | $27.97M | $1.43B | $2.25B | $27.56M | $2.22B |
| Free cash flow | $60.08M | -$23.57M | -$593.95M | $746.11M | -$3.63B | $466.15M | -$981.91M | -$1.88B | $237.13M | -$2.01B |
| Dividends paid | $321.08M | $615.39M | $698.53M | $643.47M | $567.97M | $411.70M | $363.91M | $326.73M | $218.39M | $182.98M |
| Investing cash flow | $1.32B | $517.56M | $396.06M | -$3.86B | -$2.95B | -$4.88B | $564.18M | -$2.36B | -$926.54M | -$1.95B |
| Financing cash flow | -$1.48B | -$1.02B | -$1.34B | $2.95B | $1.40B | $5.04B | -$345.87M | $2.07B | $552.56M | $1.80B |
Quarterly
| Line item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.57M | $51.75M | $384.00K | $76.69M | $59.20M | $35.26M | $74.34M | $135.42M | $214.23M | $76.53M | $135.65M | $181.09M |
| Capital expenditures | $170.84M | $142.95M | $65.37M | $195.49M | $195.49M | $108.44M | $87.05M | $76.23M | $315.89M | $263.83M | $72.90M | $360.72M |
| Free cash flow | -$152.26M | -$91.20M | -$64.98M | -$118.80M | -$136.29M | -$73.18M | -$12.70M | $59.19M | -$101.66M | -$187.30M | $62.75M | -$179.62M |
Frequently Asked Questions About MPW
What is Medical Properties Trust's annual revenue?
Medical Properties Trust reported revenue of $995.55M for the fiscal year ended Dec 31, 2024.
How fast is Medical Properties Trust's revenue growing?
Revenue was up 14.2% for the fiscal year ended Dec 31, 2024 compared with the year before. The compound annual revenue growth rate over 3 years was -13.6%.
Is Medical Properties Trust profitable?
No. Medical Properties Trust reported net income of -$2.41B for the fiscal year ended Dec 31, 2024, with a net margin of -242.1%.
How much free cash flow does MPW generate?
For the fiscal year ended Dec 31, 2024, operating cash flow of $245.48M minus capital expenditures of $185.41M produced free cash flow of $60.08M.
How much debt does Medical Properties Trust have?
The balance sheet dated Dec 31, 2024 reported long-term debt of $8.49B, short-term debt of $361.73M and cash and equivalents of $332.33M.
MPW pages: Overview, Dividends, Financials